戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              PABA 22 alone minimally increased p21 (waf1) and acetyla
2                                              PABA is observed to remain on the surface at all potenti
3                                              PABA pools were severely depleted in engineered fruit th
4                                              PABA/NO is a diazeniumdiolate of structure Me(2)NN(O)=NO
5                                         [11C]PABA and [18F]FDS were assessed for their ability to dis
6                                         [11C]PABA was the most promising tracer investigated and warr
7          In the rat S aureus VDO model, [11C]PABA could detect as few as 103 bacteria and exhibited t
8 oli was possible using a combination of [11C]PABA and [18F]FDS.
9 , a further increase of the pK(a) from 4.67 (PABA) to 5.32 (anisidine) resulted in a 2.5-fold decreas
10 n the pK(a) range from -1.7 (H(2)O) to 4.67 (PABA), with a slope of beta(nuc) = 0.80 +/- 0.1.
11                          The initiation of a PABA-deficient diet after P. yoelii infection is establi
12 ABA-deficient maternal milk, mice fed with a PABA-deficient diet after the weaning continued to contr
13 hoprim-sulfamethoxazole, rapidly accumulated PABA.
14          Protonation of p-aminobenzoic acid (PABA) and p-aminobenzoic acid methyl ester (PABAOMe) occ
15 e zwitterionic molecule p-aminobenzoic acid (PABA) at a Ag(111) electrode surface.
16 at exogenously supplied p-aminobenzoic acid (PABA) can antagonize the action of antifolates that inte
17 ike humans, can utilize p-aminobenzoic acid (PABA) for the de novo generation of folate.
18 mino acids (AroAAs) and p-aminobenzoic acid (PABA) was demonstrated in M. maripaludis.
19 mpetitive antagonist to p-aminobenzoic acid (PABA), which is a precursor of folates.
20 milk is deficient in para-aminobenzoic acid (PABA), which is required for de novo folate synthesis by
21 ve bacterial uptake: para-aminobenzoic acid (PABA), with uptake in all representative bacteria includ
22 class of broad-spectrum p-aminobenzoic acid (PABA)-based antibiotics.
23 which in turn cleaves a p-aminobenzoic acid (PABA)-peptide adduct to release free PABA and thus allow
24       Tapcin is a mixed p-aminobenzoic acid (PABA)-thiazole with a rare tri-thiazole substructure and
25 for a potent activator, 4-aminobenzoic acid (PABA): PABA-bound Best1 and Best2 structures are solved
26  containing multiple rho-aminobenzoic acids (PABAs) led us to search soil metagenomes for BGCs that p
27  was predicted to encode a unique N-acylated PABA and thiazole containing structure.
28 lex structures with a p-aminobenzyl alcohol (PABA) self-eliminating spacer showed better growth inhib
29 st step in the synthesis of p-aminobenzoate (PABA) moiety of folate remains to be elucidated.
30 n how plants synthesize the p-aminobenzoate (PABA) moiety of folates.
31 size folate from pteridine, p-aminobenzoate (PABA), and glutamate moieties.
32 synthesized from pteridine, p-aminobenzoate (PABA), and glutamate precursors.
33  by mimicking the substrate p-aminobenzoate (PABA).
34 tep in the DKFP pathway, required AroAAs and PABA for growth.
35                                Pteridine and PABA levels in transgenic fruit were >20-fold higher tha
36                                    PAHAs and PABAs exhibit strikingly different cellular effects from
37 olymer poly(3-amino-benzylamine-co-aniline) (PABA) does not only provide the suitable electrostatic c
38 te 5 and cathepsin K cleavage of the Leu-Arg-PABA element will liberate alendronic acid.
39 inyl-para-aminophenylmeth ylalcohol (Leu-Arg-PABA).
40 c acid (PAS), we hypothesized that bacterial PABA biosynthesis contributes to intrinsic antifolate re
41 he same binding site as in GABA-bound Best2; PABA treatment rescues the functional deficiency of pati
42  to produce bioactive nitric oxide (NO), but PABA/NO was the most reactive.
43 possible role for the protection afforded by PABA-deficient maternal milk, mice fed with a PABA-defic
44 ined immunodeficiency were also protected by PABA-deficient diet.
45                       Finally, dynamic (11)C-PABA PET in a 33-year-old woman with cystic fibrosis and
46                                Dynamic (11)C-PABA PET in a mouse model of M. abscessus pulmonary infe
47                           Conclusions: (11)C-PABA PET is an innovative, clinically translatable, noni
48                                Dynamic (11)C-PABA positron emission tomography (PET) was performed in
49         Measurements and Main Results: (11)C-PABA was intracellularly metabolized by M. abscessus to
50 valuated (11)C-para-aminobenzoic acid ((11)C-PABA), a chemically identical radioanalog of PABA, to de
51 hese bipartite proteins are commonly called "PABA synthases," although it is unclear whether they pro
52                         In Escherichia coli, PABA is made from chorismate in two steps.
53  malaria species, requires exogenous dietary PABA for survival.
54 pport further studies to investigate dietary PABA restriction in the management of severe malaria in
55 N,N-dimethylamino)diazen-1-ium-1,2- diolate (PABA/NO) were synthesized and studied.
56 N,N-dimethylamino) diazen-1-ium-1,2-diolate (PABA/NO) resulted in a dose-dependent increase in intrac
57 N,N-dimethylami no)diazen-1-ium-1,2-diolate (PABA/NO), liberates NO and elicits toxicity in vitro and
58 -N,N-dimethylamino)diazen-1-ium-1,2-diolate (PABA/NO), which is efficiently metabolized to potentiall
59                         We sought to explain PABA/NO's physicochemical uniqueness among these four co
60 s study highlights the potential of 2-[18F]F-PABA PET imaging for direct visualization of IE.
61                            In vivo, 2-[18F]F-PABA PET/MRI successfully visualized IE in mice.
62                                     2-[18F]F-PABA uptake by S aureus was confirmed in vitro, with acc
63            In vitro assays measured 2-[18F]F-PABA uptake by S aureus, distinguishing living bacteria
64 uates 2-[18F]F-p-aminobenzoic acid (2-[18F]F-PABA), a bacteria-specific PET tracer, for detecting IE.
65                                     Finally, PABA/NO produced antitumor effects in a human ovarian ca
66                               Our search for PABA-specific adenylation domain sequences in soil metag
67 f MAC-purified PGH revealed a K(m) value for PABA-GLU of 60 +/- 0.08 microM and a specific activity o
68 c acid (PABA)-peptide adduct to release free PABA and thus allows the growth of an auxotrophic strain
69 for phenylalanine and arylamine derived from PABA were observed.
70 nation of pyruvate and aromatization to give PABA.
71 breakdown product, p-aminobenzoyl-glutamate (PABA-GLU).
72                                  Within 4 h, PABA/NO activated the UPR and led to translational atten
73 far, the only known plant enzyme involved in PABA synthesis is ADC synthase, which has fused domains
74 onsistent with the presence of intracellular PABA/NO or metabolites, because cells overexpressing MRP
75                  Analysis of the pH-k(cat)/K(PABA) profile revealed a pK(a) of 5.52 +/- 0.14 and a so
76 e effect (SKIE) of 2.01 +/- 0.04 on k(cat)/K(PABA).
77                                 Mice fed low-PABA diets do not die from lethal doses of P. yoelii.
78 g fruit contained an average of 19-fold more PABA than controls.
79                                    Moreover, PABA was shown to be derived from an early intermediate
80  studies showed that in the absence of MRP1, PABA/NO activated the extracellular-regulated and stress
81                                           No PABA accumulation was noted by heat-inactivated bacteria
82 was added, indicating that it forms ADC, not PABA.
83 d to test the metabolism and accumulation of PABA into M. abscessus reference and clinical isolates.
84                     Exogenous application of PABA or compounds downstream in the folate biosynthesis
85 ons of a new pathway for the biosynthesis of PABA in methanococci.
86 k inhibited by physiologic concentrations of PABA, its glucose ester, or folates.
87 inhibited by physiological concentrations of PABA, its glucose ester, or folates.
88                              Cytotoxicity of PABA/NO was also examined in a mouse skin fibroblast (NI
89                                Disruption of PABA biosynthesis is also demonstrated to lead to loss o
90    Herein, we demonstrate that disruption of PABA biosynthesis potentiates the anti-tubercular action
91  a single pharmacologically relevant dose of PABA/NO, S-glutathionylation occurs rapidly (<5 min) and
92 38 were critical to the cytotoxic effects of PABA/NO.
93 ally, we demonstrate selective inhibition of PABA biosynthesis in M. tuberculosis using the small mol
94 nfirmed that a GSTpi-activated metabolite of PABA/NO was effluxed by MRP1 in a GSH-dependent manner.
95 tential on the adsorption and orientation of PABA.
96 ay be linked with the cytotoxic potential of PABA/NO.
97 PABA), a chemically identical radioanalog of PABA, to detect and localize infections due to M. absces
98  synthase, which catalyzes the first step of PABA synthesis.
99      Plasmodial enzymes for the synthesis of PABA via the shikimate pathway are being investigated as
100  the DKFP pathway, did not require AroAAs or PABA for growth.
101 otent activator, 4-aminobenzoic acid (PABA): PABA-bound Best1 and Best2 structures are solved and ill
102 xamic acids (PAHAs) and polyaminobenzamides (PABAs) were synthesized and evaluated as isoform-selecti
103 ch soil metagenomes for BGCs that polymerize PABA.
104 cid and cell wall biosynthesis, prioritizing PABA over D-Ala/D-Glu biosynthesis.
105 ombinant Arabidopsis protein did not produce PABA unless the E. coli PabC enzyme was added, indicatin
106  although it is unclear whether they produce PABA or ADC.
107 tutes a revision of the previously published PABA/NO structure.
108 mycetes, and Plasmodium spp. also synthesize PABA but have proteins comprising fused domains homologo
109 ence of biosynthetic machinery to synthesize PABA, Plasmodium yoelii, a rodent malaria species, requi
110        This is consistent with the fact that PABA/NO induces S-glutathionylation and inactivation of
111      Changes in the SFG signal indicate that PABA changes orientation in response to the charge on th
112 peared only in chloroplasts, indicating that PABA synthesis is plastidial.
113                        Studies revealed that PABA/NO's N-methyl-p-aminobenzoic acid substituent is bo
114                             We now show that PABA/NO induces nitrosative stress, resulting in undetec
115 content in food plants and that boosting the PABA supply can produce further gains.
116                 Our studies suggest that the PABA content in the diet will affect the host clearance
117 purified recombinant proteins convert ADC to PABA.
118 ion product of the PabA and PabB enzymes--to PABA and pyruvate.
119  GSTpi results in a decreased sensitivity to PABA/NO.
120 ing advanced, but there was no fall in total PABA content, which stayed between 0.7 and 2.3 nmol.g(-1
121                              When transgenic PABA- and pteridine-overproduction traits were combined
122  This study reveals that the M. tuberculosis PABA biosynthetic pathway is responsible for intrinsic r
123 AHAs inhibited HDAC >50% (1 microM), and two PABAs inhibited HDAC >50% (5 microM).
124 that whereas nitrosylation was undetectable, PABA/NO treatment caused S-glutathionylation of PDI.
125                                 Here, we use PABA-specific adenylation-domain sequences to guide the
126 ate levels 2-fold, but engineered fruit were PABA-depleted.
127 tion of cellular proteins in comparison with PABA/NO.
128                              Consistent with PABA/NO's potent suppression of A2780 human ovarian canc
129 igh in folate, and supplying such fruit with PABA by means of the fruit stalk increased their folate
130  E. coli pabA pabB double mutant and a yeast PABA-synthase deletant.

 
Page Top